HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Zotiraciclib

HCID 16739650
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1204918-72-8
Standard SMILES
CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1
InChIKey
VXBAJLGYBMTJCY-NSCUHMNNSA-N
Molecular formula
C23H24N4O
Average molar mass
372.5 g/mol
Monoisotopic mass
372.1950114

Overview

Zotiraciclib is under investigation in clinical trial NCT02942264 (Zotiraciclib (TG02) Plus Dose-dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma).

Names & identifiers

Preferred name
Zotiraciclib
IUPAC
(16E)-14-methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene
English name
Zotiraciclib
Molecular formula
C23H24N4O
Molecular weight
372.46

Names & synonyms

Zotiraciclib1204918-72-8TG02TG-02SB-1317SB-1317 free baseEx 4540D08182TTDTXSID601337151RefChem:196271DTXCID401078886SB1317
Show more names
CS-1850SB1317 (TG-02)SB1317 (Double bond E)Zotiraciclib (SB1317, TG02)VXBAJLGYBMTJCY-UHFFFAOYSA-NZotiraciclib (TG-02, SB-1317)
937270-47-8TG02 (Double bond E)Zotiraciclib [USAN](E/Z)-ZotiraciclibEX45CHEMBL1944698MFCD22124499Zotiraciclib (USAN)

Database identifiers

CAS
1204918-72-8
PubChem CID
16739650
DTXSID
DTXSID601337151
ChEMBL
CHEMBL1944698
UNII
40D08182TT

Properties

Computed structural propertiesFilling in

XLogP
4.2
Topological polar surface area
50.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
0
Heavy atoms
28
Formal charge
0
Complexity
499

Physicochemical properties

storage temp.
-20 °C · Store at -20°C
solubility
26.5 mg/mL · DMSO : 26.5 mg/mL (71.15 mM; Need ultrasonic and warming)
FDA UNII
40 D08182TT · 40D08182TT
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501
HS Code
2934999090 · 2934999090

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

hs_code
2934999090
Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Chemistry & industry

Applications

UsesTG 02 is a cyclin dependent kinase inhibitors (CDK inhibitors) for the treatment of chronic lymphocytic leukemia.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes